English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Sep 24, 2023

ARS Pharma CEO: 'We are deeply disappointed that this action further delays the availability of 'neffy' for the millions of people who are at risk of a potentially life-threatening severe allergic...

Patient Daily Report | Jul 18, 2023

Kidneys for Communities: 'The Kidneys for First Responders initiative connects those who want to support firefighters, EMTs and police officers by facilitating the living kidney donation'

Patient Daily Report | Jul 18, 2023

BioArctic CEO: FDA approval of Leqembi 'is a paradigm-shifting step in the fight against Alzheimer's disease'

Patient Daily Report | Jul 1, 2023

Akili CEO: 'We're thrilled to make EndeavorOTC available to adults who can benefit'

Patient Daily Report | Jun 28, 2023

Dr. Carolyn Bramante: Study shows 'significant impact' of metformin for COVID patients

Patient Daily Report | Jun 14, 2023

Scottsdale balloon dilation physician: 'I have personally performed over 2,000 in-office balloon sinuplasties'

Trending

Patient Daily | Aug 1, 2025

Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’

Patient Daily | Aug 4, 2025

Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’

+ Pharmaceuticals
Patient Daily | Aug 5, 2025

American Lung Association study urges schools to prioritize clean classroom air

Patient Daily | Aug 7, 2025

Dallas Breathe Free Sinus & Allergy Centers earns 4.8-star rating from 670 Google reviews

  • « First
  • «
  • …
  • 50
  • 51
  • 52
  • 53


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily